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Progressive accumulation of age relatedmitochondrial DNAmutations reduceATP production and increase
reactive oxygen species output, leading to oxidative stress, inﬂammation and degradation. The pace of this
is linked tometabolic demand. The retina has the greatestmetabolic demand andmitochondrial density in
the bodyanddisplays progressive age related inﬂammation andmarked cell loss. Near infra-red (670nm) is
thought to be absorbed by cytochrome c oxidase (COX), a key element in mitochondrial respiration and it
has been demonstrated that it improves mitochondrial membrane potentials in aged eyes. It also signiﬁ-
cantly reduces the impact of experimental pathology and ameliorates age related retinal inﬂammation.We
show ATP decline with ageing in mouse retina and brain. Also, in these tissues that ATP is signiﬁcantly
increasedby670nmexposure in oldmice. In the retina thiswas associatedwith increasedCOXand reduced
acrolein expression. Acrolein, being a free radical marker of retinal oxidative stress, is up regulated in
Alzheimer’s and retinal degeneration. This is the ﬁrst demonstration of ATP manipulation in vivo and may
provide a simple non-invasive route to combating age related tissue decline.
 2014 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/3.0/).The retina suffers with ageing. Mitochondria are the major
source of adenosine triphosphate (ATP) that provides energy for
cellular metabolism. The mitochondrial theory of ageing argues
that progressive accumulation of mutations in mitochondrial DNA
(mtDNA) reduces ATP output and increases reactive oxygen species
production driving oxidative stress, inﬂammation and cell loss
(Harman, 1981). This is marked in regions of high metabolic de-
mand such as the retina that suffers progressive inﬂammation,
extra cellular debris accumulation and cell loss (Bonnel et al., 2003;
Hoh Kam et al., 2010; Jarrett et al., 2008; Xu et al., 2009), such that
by 70 years approximately 30% of central rod photoreceptors are
lost in the human retina and a similar number in rats at 2 years
(Jackson et al., 2002; Cunea and Jeffery, 2007). This can develop into
disease in humans as there are links between mitochondrial
dysfunction and age related macular degeneration (AMD. Jarrett
et al., 2008). Inﬂammation is an early hall mark of AMD, partly
driven by deposition of pro-inﬂammatory amyloid beta in the outer
retina where this disease is initiated (Hoh Kam et al., 2010; Hoh
Kam et al., 2013; Johnson et al., 2002).Ltd. This is an open access article uIt had been thought that it was not possible to ameliorate age
related ATP decline or reduction due to disease. But it is known
that near infra-red light is absorbed by cytochrome c oxidase
(COX), complex IV of the respiratory electron transport chain
needed for ATP production (Review Fitzgerald et al., 2013). Also,
these relatively long wavelengths partially reverse age related
decline in retinal mitochondrial membranes potentials and
signiﬁcantly reduce age related retinal inﬂammation and that
associated with ocular immune vulnerability arising from the
absence of complement factor H (CFH. Begum et al., 2013;
Kokkinopoulos et al., 2012). Further, there is now evidence that
near infra-red light has the ability to preserve mitochondrial
integrity in terms of ultrastructure in response to inﬂammatory
damage in the visual system (Cummins et al., 2013). Experiments
that have explored this have commonly used 670 nm as a source in
brief administration in awide range of induced pathologies both in
the visual system and other organs (Review Fitzgerald et al., 2013).
Here we chart ATP decline in the ageing murine eye and brain. We
then show that 670 nm light exposure is directly associated with a
signiﬁcant increase in ATP. Exposure to near infra-red may
represent a simple direct route to combating age related disease in
the eye.nder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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(N ¼ 7), 4 (N ¼ 14) or 12 (N ¼ 25) months were used to chart
retinal and brain age related ATP decline. 12 months mice were
used to assess the impact of 670 nm on ATP (N ¼ 23), COX and
acrolein expression (N ¼ 10). COX is a key element in the ATP
respiratory chain. Acrolein has been used as a marker of oxidative
stress and is an end product of lipid peroxidation (Kehrer and
Biswal, 2000). It is also associated with Alzheimer’s disease and
retinal degeneration (Cimini et al., 2009; Huang et al., 2013; Jia
et al., 2007; Komeima et al., 2006), and with oxidative stress
and mitochondrial dysfunction in retinal cells (Feng et al., 2010;
Shen et al., 2005). 670 nm exposure was undertaken by scrufﬁng
mice individually and holding them approximately 15 cm from the
source (CH electronics UK) for 90 s 7 times spaced evenly over
84 h. The energy delivered was 40 mW/cm2. For ATP measure-
ments, mice were killed by decapitation and heads placed directly
in ice chilled Krebs solution where the eyes were removed. Retinae
and brains were removed in this in <1 min, with a mean extrac-
tion time for retinae of approximately 25 s. All tissues were then
placed in cell lysis reagent (ATP bioluminescence Assay Kit; Roch
UK) at 1 C. Brains used for age related changes and 670 nm
treatment were cut into small sections prior to placing in lysis
reagent. This included dividing tissue into cortex and thalamus.
Visual cortex was avoided to exclude direct visual effects. ATP was
measured with a standard luciferase protocol. Immunohisto-
chemistry: eyes were enucleated and ﬁxed in 4% para-
formaldehyde for 1 h, washed, the cornea and lens removed and
cyro-protected in 30% sucrose before embedding in OCT com-
pound. These were cryosectioned at 10 mm and mounted onto
slides before for staining with standard protocols for COX and
Acrolein. The following primary antibodies were used: COX sub-
unit VIb (rabbit monoclonal 1:200, Abcam, Cambridge, UK) and
Acrolein (rabbit polyclonal 1:200, Abcam, Cambridge, UK), fol-
lowed by incubation with the appropriate Alexa ﬂuor secondary
antibody, donkey-anti rabbit 568 (1:2000, Invitrogen, Paisley, UK).
Negative controls were with primary antibody omitted. Intensity
of label was measured using standard procedures, which have
recently been shown to be tightly correlated with independentFig. 1. ATP content in the retina and brain. A. Retinal ATP levels at 2, 4 and 12 months. ATP sh
4 and 12 months was not signiﬁcant. Two months was selected as the initial time point as e
exposures at 40 mW/cm2. This signiﬁcantly increased retinal ATP compared with aged matc
between 2 and 4 month and between 2 and 12 months. There was also a signiﬁcant differe
signiﬁcantly increased ATP levels in the cortex compared to aged matched controls. E. In
increased ATP levels here, although to a lesser extent than in the cortex. The number of mice
brain age related ATP decline. Additionally, to assess the impact of 670 nm on ATP furthermeasurements of the same features using qPCR and Western blot
analysis validating this method in mice retinae (See Fig. 3. Begum
et al., 2013). Statistical analysis was undertaken using a single
tailed ManneWhitney U test.
Retinal and brain ATP concentrations were measured in mice at
2, 4 and 12 months of age. The respective ATP concentrations in the
retina with ageing were approximately 22,000, 18,000 and
15,000 pm/mg at 2, 4 and 12 months. The decline in retinal ATP
with age was statistically signiﬁcant between 2 and 4 months and
between 2 and 12 months (P < 0.05 and P < 0.01 respectively.
Fig. 1A). When 12 month old mice were exposed to 670 nm for 90 s
7 times spaced over 84 h at an energy level of 40 mW/cm2 there
was signiﬁcant increase in retinal ATP of just under 20% from
around 14,000 to 17,000 pm/mg (P < 0.05. Fig. 1B).
In the brain ATP concentrations showed a similar age related
decline as the retina, being approximately 7000, 5000 and 3000pm/
mg at 2, 4 and 12 months. The content of ATP was signiﬁcantly
different between all ages (Fig. 1C. P < 0.01, 2e4 months. P < 0.001,
2e12 months, P < 0.01, 4e12 months). Additionally, there was a
more than 3-fold greater concentration of ATP in the retina
compared with the brain at all ages (Fig. 1). These results are
consistentwith the very highmetabolic demandof the retina and its
high density of mitochondria in photoreceptor inner segments.
Again 670 nm exposure signiﬁcantly increased ATP in both the
cortex (P < 0.01 Fig. 1D) and the thalamus (P < 0.05 Fig. 1E).
COX is essential for mitochondrial function. Retinal ATP increase
via 670 nm exposure was correlated with a signiﬁcant increase in
COX expression in the outer retina where mitochondrial density is
at its greatest (Fig. 2A,B and E P < 0.01). COX was also up-regulated
in the outer plexiform layer (OPL), but this was not measured
because it remained relatively diffuse. Adjacent sections were also
stained for acrolein, a molecule associated with free radicals and
oxidative stress (Calingasan et al., 1999; Cingolani et al., 2006). This
showed a signiﬁcant decrease (Fig. 2C,D and F. P< 0.01) in the outer
retina in the same regions where COX was elevated.
This is the ﬁrst study showing ATP modulation in vivo by an
external stimulus. However, near infra-red wavelengths have been
used by many labs in diverse tissues to ameliorate inducedowed a signiﬁcant decline between 2 and 4, and 2 and 12 months. The decline between
ye size is approximately adult like. B. 12 month old mice were given seven 90 s 670 nm
hed controls. C. Brain ATP levels at 2, 4, and 12 months. ATP shows a signiﬁcant decline
nce between 4 and 12 months. D. 12 months old mice were exposed to 670 nm, which
the same mice the thalamus was examined and 670 nm exposure also signiﬁcantly
used were at 2 (N ¼ 7), 4 (N ¼ 14) or 12 (N ¼ 25) months were used to chart retinal and
23 mice were used.
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ervation in pathology may have been the mechanism, but this has
never been demonstrated in vivo (Review Fitzgerald et al., 2013).
However, as studies in different ﬁelds have often used different key
words and phrases in their manuscript titles, the magnitude of
publications in this ﬁeld of research is largely underestimated. In
spite of this, our results go some way to conﬁrming that up regu-
lation of ATP may be part of the mechanism common to many of
these experiments.
We have also shown that 670 nm retards normal age related
retinal inﬂammation, potentially via improved mitochondrial
membrane potentials (Kokkinopoulos et al., 2012). We have also
shown that it reduces inﬂammation in CFH/ mice, which are
immune-compromised and suggested as a model of AMD (Begum
et al., 2013). A further link between mitochondrial function and
670 nm comes from Cummins et al. (2013) who have shown that
670 nm partially blocks degenerative changes induced by optic
nerve section probably by halting decline in mitochondrial ultra-
structure and preserving elements of the citric acid cycle.
The in vivo demonstrations of the impact of 670 nm are sup-
ported by in vitro studies on liver mitochondria and neuronal cul-
tures (Liang et al., 2008; Passarella et al., 1984). Also, cellular
exposure of lymphocytes with 632.8 nm results in signiﬁcant
changes tomitochondrial morphology in 1 h (Manteifel et al., 1997).
Similar results have been found in yeast cells where exposure
expanded the mitochondrial matrix that may be associated with
increased energy transfer (Manteifel and Karu, 2005). While the
main aim of our study has been to showchanges in ATP as a result of
670nm inoldmicewehave also shownthat this treatment increasesFig. 2. COX and Acrolein expression in 670 nm treatedmice and controls.A and B. 670 nm res
(represented in boxed region). COX labelwas also observed in theOPL and appeared elevated fo
(F). Abbreviations. PR Photoreceptors. ONL Outer nuclear layer. OPL Outer plexiform layer. ScCOXcontent and reduces acrolein invery similar regions of the outer
retina where mitochondrial density is the greatest in the body. We
havepreviouslydemonstrated that COXexpression is elevated in the
outer retina following 670 nm exposure using immunohistochem-
istry, qPCR and Western blots, with each independent method
revealing an approximate doubling in COX content. This conﬁrms
that measurements of density of immunohistochemical staining do
accurately reﬂect changes in protein levels (Begum et al., 2013).
COX is a highly conserved soluble protein mainly localized to
mitochondria that is a component of the mitochondrial electron
transport chain. It is capable of undergoing oxidation and reduction.
It plays an essential role in the generation and maintenance of
mitochondrial transmembrane potentials that are critical for ATP
production via oxidative phosphorylation. Its release when mem-
brane potentials decline is associated with cell death. It is thought
that COX, which acts as the terminal enzyme in the electron trans-
port chain, is a light absorbing chromophore for deep red light.
When COX absorbs proton energy the redox state of the mito-
chondria is changed and there is an increase inATPproduction along
with intra-cellular calcium. However, it is unlikely to be the only
absorbing chromophore. There is much to explore in the relation-
ships between different wavelengths, their patterns of absorption
and their subsequent impacts in cellular energy production. Further
metrics undoubtedly reside in how this energy is applied in terms of
differential delivery patterns (Borutaite et al., 2013; Siletsky, 2013).
The relatively long wavelengths used at the energies applied
penetrate tissue deeply and we found similar ATP up regulation in
brains following light exposure. However, the degree of up regu-
lation depended on the depth, with a smaller increase in theulted in COXup regulation in the outer retina (E) wheremitochondrial density is greatest
llowing670nm.CandD. In the same areasAcrolein expressionwas signiﬁcantly reduced
ale bar for all images ¼ 50 mm. For COX and acrolein expression 10 mice were used.
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modest increase may be due to less light penetrating to these
deeper tissues. That up regulation occurs in the brain excluding the
visual cortex is consistent with the notion that the effect of 670 nm
is independent of visual function. The energy applied was 40 mW/
cm2 in 90 s bursts, which are standard, simply because it was the
setting on earlier commercial devices. To place this energy level in
context, indirect light energy on a clear spring morning measured
outside our lab was about 400 W/cm2 across the spectrum. Hence,
therapeutic energy levels are log units lower than direct daylight.
Also, they are from a safe part of the spectrum being conﬁned to
longer wavelengths, avoiding the shorter wavelengths associated
with tissue damage. Interestingly, Begum et al. (2013) found evi-
dence for signiﬁcant impact of 670 nm on retinal inﬂammation
when environmental light was supplemented with this wavelength
and mice were free to engage in normal activities rather than hand
held in front of the source. Here many animals slept through some
exposures or were not consistently oriented towards them when
switched on. This may suggest that the actual energy at this
wavelength that can have a therapeutic impact may be much less
than 40 mW/cm2. This is supported by our ﬁnding of increased ATP
deep in the brainwhere light is heavily ﬁltered by the fur, skin, skull
and more superﬁcial cortical regions.
Mitochondrial dysfunction is associated with AMD. Barron et al.
(2001) revealed that aged foveal photoreceptors have increased
mtDNA deletions and COX deﬁciencies, and mtDNA instability is
viewed as a critical risk factor in photoreceptor defence (Barot et al.,
2011; Jarrett et al., 2008). Photoreceptors suffer added stress as
their oxygen dependent activities are compromised by progressive
extra cellular deposition along Bruch’s membrane, which separates
them from their blood supply (Hoh Kam et al., 2010). In light of all
these factors, it is likely that this treatment will beneﬁt retinal
disease. But this need not be conﬁned to the eye, as declining ATP is
a feature of all ageing tissues. In light of this it is interesting to note
that one minor clinical trial for dry AMD presented positive results
for 670 nm at ARVO 2012 (Merry et al., 2012). Hence, there are
reasons to believe that this potential therapy has gained some
traction. The results we present here may go some way to
explaining the underlying mechanism of action for this.
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